showed a trendp = 0.09
Incident participants enrolled within 6 months of biopsy showed a trend toward higher urinary sC5b9-to-protein ratio in high-risk participants (0.15 [0.08–0.31] vs. 0.03 [0–0.20] μg/g, p = 0.09).
Incident participants enrolled within 6 months of biopsy showed a trend toward higher urinary sC5b9-to-protein ratio in high-risk participants (0.15 [0.08–0.31] vs. 0.03 [0–0.20] μg/g, p = 0.09).
Study participants with FSGS and HR APOL1 genotype tend to have higher urinary MAC levels compared to participants with LR genotype, but the difference did not reach statistical significance.